Dexamethasone Sodium Phosphate Injection, Solution
Product Images NDC 51662-1432

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexamethasone Sodium Phosphate (NDC 51662-1432). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Labeling (Serialized Vial Labeling)

Brown glass vial with a purple and silver cap containing Dexamethasone Sodium Phosphate Injection USP 4 mg/mL, a multiple-dose vial with 30 mL solution. The product is distributed by HF Acquisition Co LLC, DBA HealthFirst, with a visible label showing the product name, strength, dosage form, route of administration, and manufacturer details.*

FDA Label Image

Structure (Structure)

Chemical structure of dexamethasone sodium phosphate, showing the steroid backbone with associated hydroxyl, keto, and phosphate functional groups.*

FDA Label Image

Vial Label (Vial Label)

Label of Dexamethasone Sodium Phosphate Injection USP 4 mg/mL, 120 mg per 30 mL multiple-dose vial. The label states the drug is for intravenous, intramuscular, intra-articular, soft tissue, or intralesional use. It includes active ingredients and excipients, storage instructions, manufacturer AuroMedics Pharma LLC, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.